Aust J Gen Pract
'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package.
Xiao Y, van Gemert C, Howell J, Adamson E, Towell V, Cowie BC, Thompson AJ, Hellard M
In Australia, over a third of individuals living with chronic hepatitis B (CHB) remain undiagnosed. Evidence suggests general practitioners (GPs) can ...
Read More
Source: PubMed
Vaccine 2020 Jan 29
Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
Okenwa UJ, Dairo MD, Bamgboye E, Ajumobi O
World Health Organization recommends hepatitis B vaccine birth dose for all infants within 24 hours of birth as the most cost-effective measure to pre ...
Read More
Source: PubMed
J. Hepatol. 2020 Jan 29
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH
Acute infection of hepatitis E virus (HEV) causes varying degrees of liver damage. Although liver-related death due strictly to HEV infection is rare ...
Read More
Source: PubMed
Methods Mol. Biol.
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors.
van den Berg FT, Ely A, Arbuthnot P
RNA interference (RNAi) is a promising tool for the treatment of chronic viral infection, such as that caused by the hepatitis B virus (HBV). RNAi act ...
Read More
Source: PubMed
Methods Mol. Biol.
In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral Vector.
Mnyandu N, Arbuthnot P, Maepa MB
Chronic hepatitis B, a liver disease resulting from persisting hepatitis B virus (HBV) infection, remains a global health challenge despite the availa ...
Read More
Source: PubMed
Aust J Gen Pract
'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package.
Xiao Y, van Gemert C, Howell J, Adamson E, Towell V, Cowie BC, Thompson AJ, Hellard M
In Australia, over a third of individuals living with chronic hepatitis B (CHB) remain undiagnosed. Evidence suggests general practitioners (GPs) can ...
Read More
Source: PubMed
Vaccine 2020 Jan 29
Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
Okenwa UJ, Dairo MD, Bamgboye E, Ajumobi O
World Health Organization recommends hepatitis B vaccine birth dose for all infants within 24 hours of birth as the most cost-effective measure to pre ...
Read More
Source: PubMed
J. Hepatol. 2020 Jan 29
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH
Acute infection of hepatitis E virus (HEV) causes varying degrees of liver damage. Although liver-related death due strictly to HEV infection is rare ...
Read More
Source: PubMed
Methods Mol. Biol.
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors.
van den Berg FT, Ely A, Arbuthnot P
RNA interference (RNAi) is a promising tool for the treatment of chronic viral infection, such as that caused by the hepatitis B virus (HBV). RNAi act ...
Read More
Source: PubMed
Methods Mol. Biol.
In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral Vector.
Mnyandu N, Arbuthnot P, Maepa MB
Chronic hepatitis B, a liver disease resulting from persisting hepatitis B virus (HBV) infection, remains a global health challenge despite the availa ...
Read More
Source: PubMed
